Insider Buying: OneMedNet (NASDAQ:ONMD) Director Purchases 158,730 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa purchased 158,730 shares of the stock in a transaction on Friday, June 12th. The shares were purchased at an average price of $0.63 per share, with a total value of $99,999.90. Following the acquisition, the director owned 17,088,874 shares in the company, valued at approximately $10,765,990.62. The trade was a 0.94% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Thomas Kosasa also recently made the following trade(s):

• On Monday, May 18th, Thomas Kosasa purchased 268,817 shares of OneMedNet stock. The shares were purchased at an average price of $0.93 per share, with a total value of $249,999.81.
• On Thursday, April 23rd, Thomas Kosasa purchased 280,898 shares of OneMedNet stock. The shares were purchased at an average price of $0.89 per share, with a total value of $249,999.22.

OneMedNet Stock Performance

OneMedNet stock opened at $0.54 on Monday. OneMedNet Corporation has a 52-week low of $0.31 and a 52-week high of $4.22. The firm has a 50 day moving average price of $0.87 and a two-hundred day moving average price of $0.97. The firm has a market cap of $29.58 million, a price-to-earnings ratio of -10.87 and a beta of 1.12.

OneMedNet (NASDAQ:ONMD) last released its quarterly earnings data on Friday, May 15th. The company reported ($0.04) earnings per share for the quarter. The firm had revenue of $0.10 million for the quarter.

Institutional Investors Weigh In On OneMedNet

Several institutional investors have recently bought and sold shares of the stock. HRT Financial LP bought a new stake in shares of OneMedNet in the 4th quarter worth $32,000. Virtu Financial LLC bought a new stake in shares of OneMedNet in the 4th quarter worth $48,000. Jane Street Group LLC bought a new stake in shares of OneMedNet in the 4th quarter worth $119,000. State Street Corp grew its stake in shares of OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock worth $128,000 after acquiring an additional 34,200 shares in the last quarter. Finally, Exencial Wealth Advisors LLC grew its stake in shares of OneMedNet by 1.3% in the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after acquiring an additional 45,401 shares in the last quarter. Institutional investors own 0.95% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on ONMD shares. Wall Street Zen lowered shares of OneMedNet from a “hold” rating to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings restated a “sell (e+)” rating on shares of OneMedNet in a research note on Monday, June 1st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.